Case Study: Cerevel Therapeutics accelerates neuroscience drug discovery with Dotmatics

Unlocking Novel Targets to Treat Neuroscience Diseases at Cerevel Therapeutics

Cerevel Therapeutics, a clinical‑stage biopharmaceutical focused on treating neuroscience diseases, needed a single, secure, cloud‑based solution to support complex cross‑functional research workflows, enable CRO collaboration, protect IP, and scale as projects grew. After evaluating vendors, Cerevel selected Dotmatics — deploying the Dotmatics Platform including its web ELN, Browser/Vortex analytics, Register, and cloud hosting — to meet those requirements.

Dotmatics implemented an integrated informatics stack (ELN, Vortex analytics, Register, BioBright integrations and secure AWS hosting with one‑way CRO upload) that streamlined data capture, searching, and analysis across chemistry, biology and external partners. The result: faster, auditable workflows, real‑time inventory and re‑testing alerts, the ability to manage thousands of HTS compounds via cloud scaling, and measurable wins such as elimination of duplicate compound registrations and significant time savings for Cerevel Therapeutics.

Cerevel Therapeutics

Hanh Nho Nguyen

Director of Medicinal Chemistry